Multi‐omics analysis of pyroptosis‐related genes for prognosis and immune landscape in head and neck cancer
2024

Study on Pyroptosis-Related Genes in Head and Neck Cancer

Sample size: 528 publication Evidence: moderate

Author Information

Author(s): Zheng Shikang, Liu Qinghua, Wang Cheng, Zhang Rongqi, Peng Xin, Fan Junda, Xu Haiming, Pan Xiazhi, Chen Nanxiang, Liu Mingbo, Kai Zhao

Primary Institution: Hainan Hospital of Chinese PLA General Hospital

Hypothesis

This study aims to elucidate the role of pyroptosis-related genes in head and neck squamous cell carcinoma (HNSCC) to develop a prognostic signature.

Conclusion

The study identifies pyroptosis-related genes as significant for prognosis in HNSCC and highlights TGM2 as a potential therapeutic target.

Supporting Evidence

  • The study identified 64 pyroptosis-related genes, with 51 differentially expressed in HNSCC tissues.
  • Survival analysis linked 33 of these genes to patient outcomes.
  • A prognostic network was developed to show interrelationships among these genes.
  • Cluster B showed a significantly better prognosis than cluster A.
  • The high-risk group exhibited reduced immune function and lower expression of immune checkpoint genes.

Takeaway

Researchers looked at special genes related to a type of cell death in head and neck cancer to help predict how patients will do and found a gene that could be a target for new treatments.

Methodology

The study used multi-omics analysis, including survival analysis and clustering, on cancer samples from TCGA and GEO databases.

Limitations

The study is based on publicly available data and may not account for all variables affecting prognosis.

Participant Demographics

The study analyzed 528 cancer samples and 44 normal controls.

Digital Object Identifier (DOI)

10.1002/ctm2.70144

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication